Cargando…

Mixed adenocarcinoma and neuroendocrine prostate cancer: a case report

BACKGROUND: Neuroendocrine prostate cancer is rare but lethal. It is one of the most common extra pulmonary manifestations of small cell cancer. CASE PRESENTATION: Here we present a case report of a 53-year-old male who presents with a mixed adenocarcinoma and neuroendocrine prostate tumor on a back...

Descripción completa

Detalles Bibliográficos
Autores principales: Hingorani, Rittu, Young, Jessica, Alweis, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Co-Action Publishing 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246144/
https://www.ncbi.nlm.nih.gov/pubmed/25432647
http://dx.doi.org/10.3402/jchimp.v4.25176
_version_ 1782346476489277440
author Hingorani, Rittu
Young, Jessica
Alweis, Richard
author_facet Hingorani, Rittu
Young, Jessica
Alweis, Richard
author_sort Hingorani, Rittu
collection PubMed
description BACKGROUND: Neuroendocrine prostate cancer is rare but lethal. It is one of the most common extra pulmonary manifestations of small cell cancer. CASE PRESENTATION: Here we present a case report of a 53-year-old male who presents with a mixed adenocarcinoma and neuroendocrine prostate tumor on a background of previously normal prostate-specific antigen (PSA). His initial symptoms prior to diagnosis included decreased urine output and acute kidney injury (AKI). CONCLUSION: Neuroendocrine tumor does not elevate the PSA level and hence is often a late finding with a poor prognosis. Special staining on histopathogy is required to reveal this diagnosis.
format Online
Article
Text
id pubmed-4246144
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Co-Action Publishing
record_format MEDLINE/PubMed
spelling pubmed-42461442014-12-15 Mixed adenocarcinoma and neuroendocrine prostate cancer: a case report Hingorani, Rittu Young, Jessica Alweis, Richard J Community Hosp Intern Med Perspect Case Report BACKGROUND: Neuroendocrine prostate cancer is rare but lethal. It is one of the most common extra pulmonary manifestations of small cell cancer. CASE PRESENTATION: Here we present a case report of a 53-year-old male who presents with a mixed adenocarcinoma and neuroendocrine prostate tumor on a background of previously normal prostate-specific antigen (PSA). His initial symptoms prior to diagnosis included decreased urine output and acute kidney injury (AKI). CONCLUSION: Neuroendocrine tumor does not elevate the PSA level and hence is often a late finding with a poor prognosis. Special staining on histopathogy is required to reveal this diagnosis. Co-Action Publishing 2014-11-25 /pmc/articles/PMC4246144/ /pubmed/25432647 http://dx.doi.org/10.3402/jchimp.v4.25176 Text en © 2014 Rittu Hingorani et al. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Hingorani, Rittu
Young, Jessica
Alweis, Richard
Mixed adenocarcinoma and neuroendocrine prostate cancer: a case report
title Mixed adenocarcinoma and neuroendocrine prostate cancer: a case report
title_full Mixed adenocarcinoma and neuroendocrine prostate cancer: a case report
title_fullStr Mixed adenocarcinoma and neuroendocrine prostate cancer: a case report
title_full_unstemmed Mixed adenocarcinoma and neuroendocrine prostate cancer: a case report
title_short Mixed adenocarcinoma and neuroendocrine prostate cancer: a case report
title_sort mixed adenocarcinoma and neuroendocrine prostate cancer: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246144/
https://www.ncbi.nlm.nih.gov/pubmed/25432647
http://dx.doi.org/10.3402/jchimp.v4.25176
work_keys_str_mv AT hingoranirittu mixedadenocarcinomaandneuroendocrineprostatecanceracasereport
AT youngjessica mixedadenocarcinomaandneuroendocrineprostatecanceracasereport
AT alweisrichard mixedadenocarcinomaandneuroendocrineprostatecanceracasereport